Evaluating the protective effects of Atorvastatin compared with Atorvastatin- Coenzyme Q10 co-administration on level of GFAP in patients with stroke

Vice chancellor for research, Shahid Beheshti University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•(patients with ischemic stroke involving the middle cerebral artery, confirmed by computed tomography scanning and clinical symptoms; range of age 50-70 years; not to receive statins continuously before entering the study; not to receive antioxidants (such as vitamin C and E) constantly; not to receive anti-inflammatory drugs (steroids, nonsteroidal anti-inflammatory) constantly; not affected by AIDS and neurodegenerative diseases (e.g. Alzheimer's, Parkinson's, amyotrophic lateral sclerosis, multiple sclerosis); no loss of consciousness level due to any reason except stroke (such as shock, alcohol consumption or intoxication); non-pregnancy; non-epilepsy; patient`s consent).Exclusion criteria: (patient's death during the study; lack of patient`s availability to follow-up; no tendency to attend in next follow-up).

发起方

Vice chancellor for research, Shahid Beheshti University of Medical Sciences